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A B S T R A C T
Objectives: Epigenetic mechanisms have been suggested to play a role in the link between in utero exposure to
bisphenol A (BPA) and pediatric obesity; however, there is little evidence regarding this mechanism in humans.
We obtained data on obesity-associated CpG sites from a previous epigenome-wide association study, and then
examined whether methylation at those CpG sites was influenced by prenatal BPA exposure. We then evaluated
the relationship between CpG methylation status and body mass index (BMI) in a prospective children’s cohort at
ages 2, 4, 6, and 8 years.
Methods: Methylation profiles of 59 children were longitudinally analyzed at ages 2 and 6 years using the
Infinium Human Methylation BeadChip. A total of 594 CpG sites known to be BMI or obesity-associated sites
were tested for an association with prenatal BPA levels, categorized into low and high exposure groups based on
the 80th percentile of maternal BPA levels (2.68 μg/g creatinine), followed by an analysis of the association
between DNA methylation and BMI from ages 2–8.
Results: There was a significant increase in the methylation levels of cg19196862 (IGF2R) in the high BPA group
at age 2 years (p = 0.00030, false discovery rate corrected p < 0.10) but not at age 6. With one standard
deviation increase of methylation at cg19196862 (IGF2R) at age 2 years, the linear mixed model analysis re-
vealed that BMI during ages 2–8 years significantly increased by 0.49 (95% confidence interval; 0.08, 0.90) in
girls, but not in boys. The indirect effect of prenatal BPA exposure on early childhood BMI through methylation
at cg19196862 (IGF2R) at age 2 years was marginally significant.
Conclusions: Prenatal exposure to BPA may influence differential methylation of IGF2R at age 2. This result
indicates that a possible sensitive period of DNA methylation occurs earlier during development, which may
affect BMI until later childhood in a sex-specific manner.
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1. Introduction
Bisphenol A (BPA) is one of the most synthesized chemicals
worldwide, and is used in industry to manufacture polycarbonate
plastics and resins, thermal merchandise receipts, food cans, dental
fillings, and medical equipment (Braun 2017). BPA is ubiquitously
found in polycarbonate water bottles, food storage containers, and
water supply pipes. Humans are mainly exposed to BPA through oral
ingestion, but can also be exposed via inhalation of dust or dermal
contact with thermal receipts (von Goetz et al. 2010). BPA has been
widely detected not only in human urine samples in various popula-
tions, including pregnant women and children (Myridakis et al. 2015;
Romano et al. 2015; Vandenberg et al. 2010), but also in the placenta
(Balakrishnan et al. 2010), amniotic fluid, and human breast milk
(Vandenberg et al. 2007), suggesting in utero BPA exposure and con-
tinuous postnatal exposure in childhood.
Prenatal exposure to BPA has been indicated as an obesogen in
pediatric epidemiological studies, although the results are inconsistent,
depending on the sex and age at adiposity measurement. In the case of
boys, Vafeiadi et al. (2016) found a positive association between pre-
natal BPA exposure and body mass index (BMI)-Z score only in boys at
age 4, while Hoepner et al. (2016) and Harley et al. (2013) reported
null effects of BPA on BMI Z-score in boys at age 7. For girls, Hoepner
et al. (2016) found a positive association between prenatal BPA ex-
posure and fat mass index and waist circumference (WC) in girls only at
age 7, while Vafeiadi et al. (2016) and Harley et al. (2013) showed a
negative association between BMI Z-score and percent body fat at age 9.
Animal studies have shown the effect of maternal BPA exposure on
DNA methylation and obesity in a sex-specific manner. In utero and
lactational exposure to BPA in mice results in sex-dependently altered
metabolic phenotypes in offspring, in which male mice showed a dose-
dependent increase in body and liver weights, while female mice
showed a dose-dependent decrease in body, liver, fat pad weights, and
adipocyte sizes (van Esterik et al. 2014). Since the association between
prenatal BPA and obesity-related phenotypic changes is more consistent
in female mice, the methylation patterns were further analyzed in fe-
male mice, which showed differential methylation patterns in the liver
tissue of female offspring (van Esterik et al. 2015).
In a cohort study of children, the second and highest tertile of
maternal urinary BPA during the second trimester is associated with
higher IGF2 methylation in children at age 14 compared to the lowest
tertile (Goodrich et al. 2016), although it was not investigated whether
such methylation changes led to body weight changes. Another epige-
netic epidemiological study showed that in utero exposure to BPA is
related to hypomethylation in theMEST gene promoter in cord blood as
well as increased expression of MEST, which in turn, is associated with
an increase in the BMI Z-score in children (Junge et al. 2018), although
sex-dependent effects were not shown. Obesity-related methylation
changes have been reported in a few Eepigenome-wide association
studies (EWAS) in children (Huang et al. 2015; Rzehak et al. 2017;
Sharp et al. 2017); however, it remains unknown whether such me-
thylation changes are related to early life environmental exposures.
We aimed to identify whether differentially methylated CpG sites
resulted from prenatal BPA exposure and whether such methylation
differences led to sex-specific obesity in early childhood. We used data
from a prospective children’s cohort study including prenatal BPA ex-
posure, methylation assessment at ages 2 and 6, and longitudinal BMI
data from ages 2, 4, 6, and 8. Since we were interested in prenatal BPA
exposure and early life methylation changes, specifically associated
with obesity, we focused on analyzing targeted CpG sites from previous
obesity-related EWAS rather than exploring the whole epigenome.
2. Methods
2.1. Study participants
We used data from the Environment and Development of Children
(EDC) Study, an ongoing prospective cohort study designed to evaluate
the effects of early-life environmental exposures on physical and neu-
robehavioral development, as described previously (Kim et al. 2018). A
total of 726 children [2-year old (n = 425) and 4-year-old (n = 301)
children] were firstly recruited for the EDC cohort during 2012–2015,
who were born from mothers participating in the Congenital Anomaly
Study cohort, and followed-up at 2-year intervals. Mothers’ urine
samples were collected during the second trimester of pregnancy, al-
though cord blood was not collected. In this sub-study, methylation
profiles were analyzed at ages 2 and 6 years in 59 children among those
who visited from ages 2, 4, 6, to 8 years. Informed consent was obtained
in line with the Institutional Review Board of Seoul National University
College of Medicine (IRB No. 1201-010-392).
2.2. Outcome definitions
Height was measured using a Harpenden stadiometer (Holtain Ltd.,
Crymych, Wales, UK) and weight was measured using a digital scale
(150 A; Cas Co. Ltd., Seoul, Korea) by trained personnel. BMI was
calculated as weight/height2 (kg/m2). The Z-scores for height, weight,
and BMI were assigned on the basis of the 2007 Korean National
Growth Charts (Moon et al. 2008). An extensive questionnaire in-
cluding birth history, family history, past medical history, socio-
economic status, lifestyle factors including diet, and environmental
toxicant exposure in mothers and children, was completed by the par-
ents at every visit.
2.3. Prenatal exposure
Urine BPA was measured as described in a previous study (Lim et al.
2017a). The first void urine in the morning was collected in conical
tubes (SPL Lifesciences, Pocheon, Gyunggii-do, Korea) from mothers
and children after 8 hours of fasting. Maternal urine was collected
during the second trimester of pregnancy (15–27 weeks, mean 20 weeks
of gestation), and the samples were stored at−20 °C (Seegene Medical
Foundation, Seoul, Korea). Total BPA concentrations, including free
and conjugated species, were measured, and the conjugated BPA spe-
cies were hydrolyzed with β-glucuronidase/sulfatase. BPA concentra-
tions were quantified by high-performance liquid chromatography-
tandem mass spectrometry (Agilent 6410 Triple Quad LCMS; Agilent,
Santa Clara, CA, USA) (Yang et al. 2003). Standard BPA solutions were
prepared at 50, 25, 12.5, 6.25, 3.125, and 1.5625 μg/L, and analyzed
using a blank to determine the standard calibration curve
(r2 > 0.999). When the measured concentration of a sample was above
the maximum level of the standard BPA solution, the sample was di-
luted (1:1) and re-analyzed. The sample was also re-analyzed if the
detected concentration was not within 20% of the standard calibration
curve. The lower limit of detection (LOD) ranged from 0.031 to
0.212 μg/L, depending on the batch, and we used a LOD value of 0.212/
√ 2. We used creatinine-adjusted BPA values in units of μg/g creatinine
throughout our analysis (Calafat et al. 2005).
2.4. DNA methylation
2.4.1. Assessment of DNA methylation
DNA methylation was measured in whole blood samples repeatedly
obtained at ages 2 and 6 from 59 children. The quality of the DNA
samples was checked using the NanoDrop® ND-1000 UV–Vis
Spectrophotometer (Thermo Fisher Scientific, Wilmington, DE, USA).
After electrophoresis on a 1% agarose gel, samples with intact genomic
DNA (gDNA) were selected, and then diluted to 50 ng/μL based on
Y.-J. Choi, et al. Environment International 143 (2020) 105929
2
Quanti-iT Picogreen quantification (Thermo Fisher Scientific,
Wilmington, DE, USA). At least 500 ng of gDNA was bisulfate-converted
according to the Zymo EZ DNA methylation kit (Zymo Research, Irvine,
CA, USA). Bisulfite-converted DNA was amplified (×1000) to be used
on a single BeadChip. The Illumina Infinium HumanMethylation 450K
BeadChip was used for blood samples at age 6 (Illumina, San Diego, CA,
USA). Since the HumanMethylation 450K BeadChip was no longer
available at Illumina, the Illumina Infinium HumanMethylation EPIC
BeadChip (850K) was used for blood samples at age 2 (Illumina, San
Diego, CA, USA). The amplified DNA was fragmented and hybridized
using 50-mer capture probes at CpG loci. For the allele-specific single-
base extension assay, primers were extended with a polymerase and
labeled nucleotide mix (Two-Color Extension Master Mix) (Illumina,
San Diego, CA, USA), stained with the staining and anti-staining re-
agents, followed by washing and coating. The image was read by the
Illumina BeadArray Reader, and image intensities were extracted using
Illumina GenomeStudio software. Microarrays were processed at
Macrogen (Seoul, Korea).
Raw data were extracted as beta values for each CpG. Beta values
were calculated by taking the ratio of the methylated signal intensity
over the sum of methylated and unmethylated signals at the 5th carbon
(%5mC), which ranged from 0 (no methylation) to 100 (fully methy-
lated). Each signal was subtracted from the background signals from the
negative control. Gene-enrichment and functional annotation analyses
for each probe list were performed using the Database for Annotation,
Visualization, and Integrated Discovery (http://david.abcc.ncifcrf.gov/
home.jsp).
2.4.2. Quality control of methylation data
A detection p-value < 0.05 was applied for the filtering criterion.
Array CpG probes that had a detection p-value ≥ 0.05 in more than
25% of samples were more likely to be signal to noise and were thus
filtered out. Filtered data were normalized using the Beta Mixture
Quantile (BMIQ) method (Teschendorff et al. 2013). For the Hu-
manMethylation EPIC BeadChip (850K), CpG sites with “not-available”
(NA) values for at least one sample for BMIQ normalization were ex-
cluded, leaving 865,688 CpG sites to be analyzed from 866,297 CpG
sites in total. For the HumanMethylation 450K BeadChip, CpG sites
with NA values of at least one sample for BMIQ normalization were
excluded, leaving 460,960 CpG sites for analysis from 485,577 CpG
sites in the raw data. Furthermore, CpG sites that corresponded to non-
CpG loci or the X or Y chromosome were excluded from further ana-
lysis. The exclusion of single nucleotide polymorphism (SNP)-asso-
ciated CpG sites is described below.
2.4.3. Targeting CpG sites for analysis
Since we were specifically interested in the question of whether
DNA methylation mediates the effects of prenatal BPA exposure on
child obesity, we targeted CpG sites that were more likely to be in-
volved in obesity rather than scanning the whole epigenome. For the
selection of previous EWAS in association with obesity, we searched
Pubmed on February 7, 2019, using keywords such as “epigenome-wide
association study” and (“BMI” or “obesity”) without specific term
limits. The selection criteria were EWAS-performed in association with
BMI or obesity in healthy adults or children. A total of 24 articles were
identified, and we excluded irrelevant articles such as EWAS performed
in association with diabetes or in patients with a specific diagnosis such
as leukemia or prostate cancer, leaving 12 relevant studies. Using a
bibliographic search, we included three additional articles, which re-
sulted in 15 articles for the selection of relevant CpG sites (Al Muftah
et al. 2016; Aslibekyan et al. 2015; Campanella et al. 2018; Demerath
et al. 2015; Dhana et al. 2018; Huang et al. 2015; Kvaloy et al. 2018;
Lin et al. 2017; Rzehak et al. 2017; Sayols-Baixeras et al. 2017; Sharp
et al. 2015; Sharp et al. 2017; Wahl et al. 2017; Wilson et al. 2017; Xu
et al. 2018) (Table S1). From previous EWAS that investigated the as-
sociation between DNA methylation and obesity in adults and children,
we extracted CpG sites associated with obesity-related parameters such
as BMI, BMI Z-score, WC, and fat mass index, resulting in a total of 1100
CpG sites (Table S2).
Duplicate CpG sites reported in more than two studies (210 CpG
sites) were excluded, leaving 890 CpG sites (Fig. S1). Among the 890
CpG sites, 135 CpG sites were located within a 0–1 base pair extension
from known SNPs, 49 CpG sites had a minor allele frequency
(MAF) ≥ 0.05 in SNPs within the target region, and 25 CpG sites cor-
responded to both occasions, which included up to 209 CpG sites. These
CpG sites were excluded from our analysis because the effect of me-
thylation at these CpG sites could be confounded by the effects of the
SNPs. Since we matched CpG sites that were present in both the Hu-
manMethylation EPIC BeadChip and the HumanMethylation 450K
BeadChip, 87 CpG sites that were only present in either BeadChip were
excluded, leaving 594 CpG sites for analysis.
2.5. Covariates
We included covariates in the models to investigate the associations
between DNA methylation levels and BMI or BMI Z-score at ages 2, 4, 6,
and 8 as follows: mother’s age at pregnancy (years), mother’s and fa-
ther’s BMI when a child first visited at age 2 (kg/m2), maternal smoking
status (smoked during pregnancy, did not smoke during pregnancy but
smoked before pregnancy, and never smoked), mother’s educational
level (middle school graduate, high school graduate, college graduate,
or graduate school attendance), preterm birth (< 37 weeks
or ≥ 37 weeks), underweight at birth (< 2,500 g or ≥ 2,500 g),
breastfeeding duration (≥6 months or < 6 months), and child’s ca-
loric intake (kcal/day) at ages 4, 6, and 8 (unavailable at age 2), which
were adjusted at corresponding ages. Prenatal information was ob-
tained using a questionnaire and confirmed by trained research per-
sonnel during an interview. Dietary information was obtained from
food frequency questionnaires (FFQs) by a dietitian. In a sensitivity
analysis, multiple births (singleton or twin/triplet) and maternal al-
cohol consumption (drank during pregnancy, did not drink during
pregnancy but drank before pregnancy, and never drank) were ad-
ditionally adjusted. The child’s urinary BPA level was measured using
the same method as for the mother’s urinary BPA. Child’s urinary BPA
levels were available only at age 4, 6, and 8, and was not adjusted in the
model because it was considered unrelated with DNA methylation at
age 2, thus not a confounder. Nonetheless, we presented the data to
compare with maternal BPA levels (Table 1).
For the estimation of cell-type distribution in blood samples, we
used an adult leukocyte reference panel, as suggested by Houseman
et al. (2012). The Minfi R package was used to estimate the cell-type
fraction in each blood sample (Aryee et al. 2014). Fractions of cell types
including CD8+ T cells, CD4+ T cells, natural killer (NK) cells, B cells,
monocytes, and neutrophils were also adjusted for in the models to
examine the association between methylation and child obesity.
2.6. Statistical analysis
Characteristics of the study participants were analyzed using
Student’s t-test for continuous variables, and a chi-square test or
Fisher’s exact test for categorical variables to compare two groups.
Fifty-nine samples at ages 2 and 6 were independently run on a
single batch. Batch effects by chips and positions were adjusted using
ComBat packages in R (Johnson et al. 2007). We used the unadjusted
data as we used a single batch, and batch effects by chips or positions
were not apparent (Fig. S2a-b). We performed sensitivity analyses of
the main findings with batch effects-corrected data.
We searched for differentially methylated CpG sites at ages 2 and 6,
significantly different according to prenatal BPA exposure. Prenatal
BPA exposure groups were categorized into low (< 2.68 μg/g creati-
nine) and high (≥2.68 μg/g creatinine) exposure group based on the
80th percentile of maternal BPA levels during the 2nd trimester among
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the EDC cohort who visited at 2 years. We also conducted a sensitivity
analysis on the basis of various cutoff values of high BPA levels (e.g.,
75th, 80th, and 90th percentiles of maternal BPA concentrations).
When examining the distribution of 594 CpG sites by histograms
and QQ plots, we found 565 unimodal, 15 bimodal, and 14 trimodal
CpG sites. For the unimodal CpG sites, normality was tested using the
Shapiro-Wilk test, and differences in the means of methylation levels
were compared by prenatal BPA exposure using Student’s t-test. For the
bimodal and trimodal CpG sites, the continuous methylation levels
(beta values) were converted to categorical variables [bimodal (0, 1),
and trimodal (0, 1) or (0, 2)] by visually inspecting histograms and QQ
plots (Fig. S3a-b). A significance level was defined as a false discovery
rate (FDR)-corrected p-value < 0.10 for multiple comparisons, ac-
cording to the Benjamini and Hochberg (1995) method.
We constructed a linear mixed model using random intercepts to
evaluate the effect of methylation on repeated BMI measurements
during the ages of 2–8 years. Methylation levels at cg19196862 were
then tested for their association with BMI at 2, 4, 6, and 8 years with
linear regression analysis adjusted for the covariates as elaborated
earlier. A p-value < 0.05 was used for evaluating statistical sig-
nificance for the regression analyses. Although there was an issue of
multiple comparisons of testing the BMI or BMI Z-scores at ages 2, 4, 6,
and 8, we considered that it would be difficult to conclude that the
associations between obesity-related DNA methylation levels and BMI
in children at different ages were independent of each other. Therefore,
we did not adjust for multiple comparisons in the regression analysis.
Estimations from the linear regression were multiplied by one
standard deviation (SD) at each CpG site to produce the change in the
BMI or BMI Z-scores by one SD change of methylation levels. Sex-spe-
cific estimates were computed by adding a term for the sex effect as
well as an interaction term of the sex effect and DNA methylation
(sex × methylation) instead of stratification, while retaining statistical
power. We estimated the intraclass correlation coefficient (ICC) to
evaluate the stability of methylation between the ages of 2 and 6 years,
Table 1
General characteristics of study participants according to mothers’ BPA exposure levels.
Participants Variables Low maternal BPA (n = 51) High maternal BPA (n = 8) p-value
Mother Age at pregnancy (years) 31.3 ± 3.8 29.5 ± 3.4 0.209
BMI (kg/m2) 22.7 ± 3.4 24.0 ± 6.6 0.594
Educational level Middle school graduate 0 (0%) 0 (0%) NA
High school graduate 7 (13.7%) 2 (25.0%)
College graduate 39 (76.5%) 3 (37.5%)
Graduate school attendance 5 (9.8%) 3 (37.5%)
Urinary BPA in the 2nd trimester of pregnancy (μg/g
creatinine)
Urinary BPA 1.34 ± 0.60 7.92 ± 4.97 0.007
Maximum urinary BPA 2.77 18.38
Smoking status during pregnancy Never smoked 27 (52.9%) 2 (25.0%) NA
Smoked tobacco before
pregnancy
19 (37.3%) 5 (62.5%)
Smoked tobacco during
pregnancy
5 (9.8%) 1 (12.5%)
Alcohol consumption during pregnancy Never consumed alcohol 11 (26.2%) 0 (0%) NA
Consumed alcohol before
pregnancy
20 (47.6%) 3 (50%)
Consumed alcohol during
pregnancy
11 (26.2%) 3 (50%)
Father BMI (kg/m2) 25.5 ± 3.4 25.0 ± 3.3 0.692
Child Sex Male 23 (45.1%) 5 (62.5%) 0.359
Female 28 (54.9%) 3 (37.5%)
Multiple births Singleton 46 (90.2%) 6 (75%) 0.238
Multiple* 5 (9.8%) 2 (25%)
Preterm (< 37 weeks) No 46 (90.2%) 5 (62.5%) 0.059
Yes 5 (9.8%) 3 (37.5%)
Underweight at birth (< 2500 g) No 46 (90.2%) 8 (100%) 0.469
Yes 5 (9.8%) 0 (0%)
Breastfeeding for ≥ 6 months Yes 26 (51.0%) 4 (50%) 1.000
No 25 (49.0%) 4 (50%)
BPA exposure level 4 years 3.49 ± 2.53 3.68 ± 2.07 0.841
6 years 3.82 ± 3.26 4.13 ± 2.63 0.799
8 years 2.05 ± 1.73 0.98 ± 1.36 0.101
Total calorie intake (kcal/day) 4 years 1,464.3 ± 333.5 1,664.2 ± 481.5 0.144
6 years 1,574.5 ± 372.9 1,633.1 ± 533.7 0.699
8 years 1,583.5 ± 397.9 1,568.9 ± 493.7 0.926
BMI (kg/cm2) 2 years 16.6 ± 1.2 16.5 ± 1.2 0.782
4 years 16.0 ± 1.2 15.7 ± 0.7 0.502
6 years 16.4 ± 1.8 16.3 ± 1.3 0.925
8 years 17.7 ± 2.7 17.4 ± 1.8 0.745
BMI Z-score 2 years −0.06 ± 0.79 −0.18 ± 0.76 0.699
4 years 0.23 ± 0.88 0.06 ± 0.62 0.588
6 years 0.31 ± 0.95 0.29 ± 0.84 0.972
8 years 0.40 ± 1.08 0.31 ± 0.82 0.822
Cell type fraction CD4 T cell 0.20 ± 0.04 0.21 ± 0.04 0.613
CD8 T cell 0.15 ± 0.05 0.18 ± 0.03 0.165
NK cell 0.04 ± 0.04 0.05 ± 0.05 0.606
B cell 0.19 ± 0.04 0.15 ± 0.04 0.020
Monocyte 0.05 ± 0.02 0.04 ± 0.02 0.505
Neutrophil 0.35 ± 0.09 0.36 ± 0.08 0.796
BPA, bisphenol A; BMI, body mass index.
* Twin (n = 4) and triplet birth (n = 3).
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and further analyzed the association between longitudinal measures of
methylation at ages 2 and 6 years, along with longitudinal BMI or BMI
Z-score at ages 2 and 6 years, using a linear mixed model with random
intercepts.
We conducted mediation analyses to estimate average causal med-
iation effects (ACME) and average direct effects (ADE) of methylation
on the association between maternal BPA exposure and childhood
adiposity. Pathways were specified as in: (1) maternal BPA exposure
affecting methylation levels and (2) the methylation levels affecting the
BMI at ages 2, 4, 6, and 8, where the mediator was defined as a change
in the methylation level at a CpG site. To evaluate whether maternal
BPA exposure (log2BPA) affects methylation levels, linear regression
analysis was performed after adjusting for mother’s age and BMI, and
child’s sex. To analyze whether the methylation levels affect BMI or
BMI Z-scores at ages 2, 4, 6, and 8 years, linear regression analysis was
conducted after adjusting for maternal BPA exposure in addition to the
covariates used in the main analysis. The mediation R package was used
for the mediation analysis, and nonparametric bootstrapping with 1000
simulations was applied to estimate ACME and ADE. The proportion of
mediated indicated the average magnitude of the total mediation effect
(ACME + ADE). We used SAS (v9.4) (Cary, NC, USA) and R software
(v3.2.1) (R Development Core Team, https://cran.r-project.org/) for
statistical analyses.
3. Results
3.1. General characteristics of the participants
Table 1 shows the clinical characteristics of 59 children and the
comparison between the two groups according to prenatal BPA ex-
posure (low [n = 51] vs. high [n = 8] BPA exposure). No significant
differences were found in parental factors (maternal age at pregnancy
and mother’s and father’s BMI), child factors (sex, multiple births,
preterm birth, underweight at birth, breastfeeding duration, total ca-
loric intake, BMI, and BMI Z-score), or the cell type fraction overall
(except for the B-cell fraction) between the two groups. The mean
maternal urinary BPA levels of the low and high BPA exposure groups
were 1.34 ± 0.60 μg/g creatinine (maximum 2.77 μg/g creatinine)
and 7.92 ± 4.97 μg/g creatinine (maximum: 18.38 μg/g creatinine),
respectively.
Table S3 shows a comparison of clinical characteristics between the
59 children with methylation data analyzed in this substudy and the
remaining EDC cohort without methylation data (n = 598). Children
included in this substudy showed greater maternal BMI, a higher pro-
portion of maternal smoking or drinking history, lower postnatal BPA
exposure, greater child total caloric intake, and greater child BMI or
BMI Z-scores at ages 4, 6, and 8 than the remaining 598 children.
However, other maternal factors (prenatal BPA exposure, mother’s age
at pregnancy, and mother’s educational level) and child factors (sex,
multiple births, preterm birth, underweight at birth, and breastfeeding
duration) were not different between the two groups (Table S3).
3.2. Prenatal BPA exposure and DNA methylation
The distribution of 594 targeted CpG sites was inspected; there were
565 unimodal, 15 bimodal (Fig. 1), and 14 trimodal CpG sites. Among
565 CpG sites, 492 CpG sites (87.1%) at age 2, and 498 CpG sites
(88.1%) at age 6 showed normal distributions (p-value > 0.05 by
Shapiro-Wilk test), respectively (Table S4). When we compared me-
thylation at each CpG site between low and high BPA groups using
various cutoff values of high BPA levels (e.g., 75th, 80th, and 90th
percentiles of maternal BPA concentrations), the 80th percentile was
the most sensitive cutoff value for detecting differences in methylation
levels by prenatal BPA exposure (Table S5). Hereafter, we categorized
prenatal BPA exposure into two groups (low and high) based on the
80th percentile of maternal BPA concentrations.
We compared mean levels of methylation at unimodal CpG sites
between the prenatal low (n = 51) and high (n = 8) BPA exposure
groups. At age 2, methylation at cg19196862 significantly increased in
the high BPA exposure group compared to the low BPA exposure group
(p-value 0.00030, FDR corrected p-value < 0.10) (Table 2, Table S6,
and Fig. 2a), although this difference was not significant at age 6 (Table
S7 and Fig. 2a). The change in methylation levels at cg19196862 be-
tween ages 2 and 6 (methylation levels at age 6 subtracted by methy-
lation levels at age 2) did not differ between high and low prenatal BPA
exposure groups (Table S8). Cg19196862 is located in the 31st exon of
IGF2R out of 48 exons (Fig. 3).
For bimodal or trimodal CpG sites, Fisher’s exact test showed that
the distribution of methylation at the bimodal cg19249811 (the first
intron of SVIL gene) site was different according to prenatal BPA ex-
posure at both ages 2 and 6 years (p-value 0.0012, FDR corrected p-
value < 0.10) (Table S9 and Fig. S4).
3.3. DNA methylation and BMI
3.3.1. Methylation at cg19196862 (IGF2R) and BMI during ages 2–8 years
One SD in methylation levels at cg19196862 (IGF2R) at age 2 in-
creased BMI significantly by 0.37 (95% CI: 0.06, 0.68), 0.28 (95% CI:
0.00, 0.56), 0.29 (95% CI;−0.11, 0.69), and 0.64 (95% CI; −0.09,
1.37) at ages 2, 4, 6, and 8, respectively, when adjusted for the afore-
mentioned covariates (Table 3 and Fig. 2b). The sex difference was
significant in BMI at age 6 (p = 0.048) and 8 years (p-value = 0.046)
(Table 3).
The positive association between methylation at cg19196862
(IGF2R) at age 2 and BMI was significant only in girls in later ages, by
0.38 (95% CI: 0.00, 0.76) at age 2, 0.37 (95% CI: 0.02, 0.72) at age 4,
0.58 (95% CI: 0.10, 1.05) at age 6, and 1.19 (95% CI: 0.32, 2.07) at age
8, showing increasing effect sizes with age (Table 3 and Fig. 2b).
However, the association was not significant in boys, showing de-
creasing effect sizes with age. Next, we constructed a linear mixed
model to evaluate the effect of 2-year-old methylation at cg19196862
(IGF2R) on BMI during ages 2–8 years. With 1 SD increase of methy-
lation at cg19196862 (IGF2R) at age 2 years, the early childhood BMI
Fig. 1. Distribution of methylation at a unimodal CpG site (cg19196862
(IGF2R)) and a bimodal CpG site (cg19249811 (SVIL)) at ages 2 and 6 years.
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significantly increased by 0.49 (95% confidence interval [CI]: 0.08,
0.90) in girls, but not in boys. The association between methylation at
cg19196862 (IGF2R) and BMI Z-score is shown in Table S10 and Fig.
S5. ICC for methylation at cg19196862 (IGF2R) between ages 2 and 6
was 0.023 (2.3%) (Table S11). Paired methylation and BMI (or BMI Z-
scores) at ages 2 and 6 years showed positive associations without
significance (Table S11b).
The mediation effect of methylation at cg19196862 (IGF2R) at age 2
on the association between prenatal BPA exposure and the BMI or BMI
Z-score at ages 2, 4, 6, and 8 were analyzed, respectively, (Fig. 2c and
Table S12a-b). In the case of BMI, the indirect effect (average causal
mediation effect (ACME)) was marginally significant in early childhood
from ages 2 and 4 (p-value < 0.1).
3.3.2. Methylation at cg19249811 (SVIL) and BMI during ages 2–8 years
Methylation at cg19249811 (SVIL) at age 2 or 6 was not associated
with BMI or BMI Z-score at any ages. Furthermore, repeated measure-
ments of BMI or BMI Z-score were not associated with methylation at
cg19249811 (SVIL).
3.4. Sensitivity analysis
For sensitivity analysis, we applied various cutoff points such as the
75th, 80th, and 90th percentiles of prenatal BPA exposure levels where
methylation at cg19196862 (IGF2R) becomes different (Table S5).
Using batch effects-corrected data, we performed sensitivity analyses of
the association between prenatal BPA and DNA methylation (Table
S13) and the association between DNA methylation and BMI or BMI Z-
score (Table S14), which showed consistent results. We performed
linear regression analysis for the association of methylation level at
cg19196862 (IGF2R) with the BMI or BMI Z-scores after additionally
adjusting for multiple births and alcohol consumption during preg-
nancy, in addition to the covariates included in the main analysis (Table
S15). The effect sizes and p-values were consistent with the main ana-
lysis.
4. Discussion
When obesity-associated targeted CpG sites were compared by
prenatal BPA exposure, an increase in methylation of cg19196862
(IGF2R) levels at age 2 but not 6, and the change in bimodality of the
cg19249811 (SVIL) site at ages 2 and 6 were found in the high BPA
compared to low BPA exposure groups, categorized by the 80th per-
centile of maternal BPA levels (2.68 μg/g creatinine). Notably, the in-
creased methylation of cg19196862 (IGF2R) at age 2 years was per-
sistently associated with BMI during age 2–8 years in girls, but not boys.
The mediation effect of 2-year-old methylation at cg19196862 (IGF2R)
on the association between prenatal BPA exposure and early childhood
BMI Z-scores was marginally significant.
Epigenetic dysregulation has been suggested as one of the biological
mechanisms of the developmental origin of health and disease
(DOHaD). The DOHaD hypothesis suggests that environmental ex-
posures influence developmental programming during critical periods
of early life development, leading to permanent changes in disease
susceptibility in later life (Waterland and Michels 2007). DNA methy-
lation is a primary epigenetic mechanism involved in DOHaD. During
embryonic development, a fertilized cell undergoes epigenetic repro-
gramming at the early embryo stage, in which DNA methylation is al-
most completely erased in both the maternal and paternal genomes
(Kundakovic and Jaric 2017; Smith et al. 2014). Cell-specific DNA re-
methylation soon follows (epigenetic programming), whose patterns
are inherited from both parents. This dramatic epigenetic reprogram-
ming and programming imply that DNA methylation may be suscep-
tible to changes at earlier stages of development. Although epigenetic
marks are stabilized in the later stages of development, they are actively
involved in gene expression programming during development. For thisTa
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reason, we conducted this study to investigate early-life epigenetic
signatures associated with childhood adiposity changes and later obe-
sity development.
ICC for methylation at cg19196862 (IGF2R) between ages 2 and 6
was only 0.023 (2.3%). In this study, methylation at cg19196862
(IGF2R) site at age 2 years, but not 6 years, was persistently related to
BMI during 2–8 years. This implies dynamic changes of DNA methy-
lation during early childhood compared to later stages of development.
According to a recent genome-wide methylation study analyzing
783,659 CpG sites, the methylation status in 110,726 CpG sites changed
during the first 5 years after birth, while only 460 CpG sites changed
during the ages 5–10 (Perez et al. 2019). Importantly, the effect of
adversity on DNA methylation changes occurred during very early
childhood rather than accumulation or recency of exposures, in that
most CpG loci were predicted by early childhood adversity before
3 years of age (Dunn et al. 2019). Therefore, the early stage of child
Fig. 2. a. Methylation levels at cg19196862
(IGF2R gene) by prenatal BPA (μg/g creati-
nine) exposure (low:< 80 percentile, high:
≥80 percentile) at ages 2 and 6 years. *FDR
corrected p-value < 0.10. b. Increase in the
BMI (kg/cm2) and 95% confidence intervals
corresponding to one standard deviation
increase of methylation levels at
cg19196862 (IGF2R gene) in boys and girls
together, only boys, and only girls at ages 2,
4, 6, and 8 years. The model was adjusted
for mother’s age at pregnancy (years), mo-
ther’s and father’s BMI when a child first
visited at age 2 (kg/m2), maternal smoking
status (smoked during pregnancy, did not
smoke during pregnancy but smoked before
pregnancy, and never smoked), mother’s
educational level (middle school graduate,
high school graduate, college graduate, or
graduate school attendance), preterm birth
(< 37 weeks or ≥ 37 weeks), underweight
at birth (< 2500 g or ≥ 2500 g), breast-
feeding duration (≥6 months or <
6 months), and child’s caloric intake (kcal/
day) at ages 4, 6, and 8 (unavailable at age
2), and cell type fraction. c. Mediation ana-
lysis showing a) the association between
prenatal BPA exposure and DNA methyla-
tion at cg19196862 at age 2, b) the asso-
ciation between DNA methylation at
cg19196862 at age 2 and the BMI at age 4;
c) the association between prenatal BPA
exposure and the BMI (direct effect: prenatal
BPA → child’s BMI; indirect effect: prenatal
BPA → child’s DNA methylation → child’s
BMI). BMI, body mass index; BPA, bisphenol
A; FDR, false discovery rate.
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development, in which DNA methylation status is still prone to change,
would be more susceptible to maternal exposure to environmentally
toxic chemicals.
The significant difference in methylation levels at cg19196862
(IGF2R) at age 2 by prenatal BPA levels disappeared at age 6. This
finding suggests that prenatal toxicant exposure may influence DNA
methylation in early childhood, but this effect is mitigated as the me-
thylation profiles become more stabilized with age. As children grow
older, more diverse biological and sociological factors during the
postnatal period may come into play in determining DNA methylation.
Nonetheless, this study points out that prenatal environmental exposure
can drive sustained alterations to DNA methylation in infancy and
persistent adiposity development, in agreement with the DOHaD hy-
pothesis.
In this study, the greater the methylation of cg19196862 (IGF2R),
the greater the BMI in early childhood. IGF2R regulates the amount of
circulating IGF2 by binding, internalizing, and transporting IGF2 into
the cell lysosome and degrading it (Hassan 2003). IGF2 during fetal
development has been well documented, and IGF2 overexpression leads
to overgrowth syndromes such as Beckwith-Wiedemann syndrome
linked to overgrowth and tumorigenesis (Bergman et al. 2013). IGF2
levels were higher in obese than in normal weight children (Inzaghi
et al. 2017) and hypomethylation at IGF2 increased BMI in children
(Acs et al. 2017; Do et al. 2019). The mechanism of IGF2R methylation
and obesity has not yet been investigated in animal or human studies.
We hypothesized that hypermethylation of IGF2R may decrease IGF2R
expression and insufficient degradation of IGF2, leading to an increase
in IGF2 levels, Fig. 3 overgrowth and obesity, although the regulatory
effect of methylation in the body of the gene is controversial. Further
studies are mandatory to prove our hypothesis for the role of
cg19196862 (IGF2R) methylation on IGF2R expression, IGF2 levels, and
obesity development.
Methylation status at the bimodal CpG site, cg19249811(SVIL),
differed by prenatal BPA exposure at ages 2 and 6 years, but it was not
associated with BMI in this study. The function of SVIL gene is not
clearly known, but is reported to be involved in the tight link between
actin cytoskeleton and cell membrane (Ghoshdastider et al. 2013). Bi-
modal and trimodal CpG sites are mostly associated with single nu-
cleotide polymorphisms (SNPs). Genetic loci, usually SNPs, that are
associated with different levels of DNA methylation, are called me-
thylation quantitative trait loci (meQTL) (Bell et al. 2011). SNP can
cause a bimodal distribution of methylation in CpG sites near SNPs;
thus, meQTL needs to be investigated with regard to prenatal en-
vironmental exposure and ‘genetics × epigenetics’ interaction.
In this study, mediation analysis showed indirect effects of BPA on
BMI through DNA methylation at IGF2R at ages 2 and 4, although only
marginally significant (Table S12a-b). The adipogenic effect of BPA has
been suggested by several mechanisms: an estrogen receptor-dependent
mechanism (Ohlstein et al. 2014), the thyroid receptor/retinoic X re-
ceptor or mammalian target of rapamycin signaling pathways (Boucher
et al. 2014), increasing 11β-hydroxysteroid dehydrogenase type 1 ac-
tivity (Wang et al. 2013), and epigenetic mechanisms. There have been
suggestions that epigenetic mechanisms are involved in obesogenic
effect of BPA. Previous animal studies have shown that developmental
BPA exposure changes methylation in candidate genes or global me-
thylation assays (Anderson et al. 2012; Dolinoy et al. 2007). In terms of
energy metabolism and body fat, DNA methylation status at Janus ki-
nase-2 (Jak-2), retinoid X receptor (Rxr), regulatory factor x-associated
protein (Rfxap), and transmembrane protein 238 (Tmem 238) were
identified as mediators using the epigenome-wide discovery platform to
evaluate epigenetic alterations in liver tissue from female offspring
following prenatal BPA exposure (Anderson et al. 2017).
This study has several limitations. It was limited by the small sample
size and lack of genome and gene expression data. Although the dif-
ferent methylation of the cg19196862(IGF2R) CpG site by prenatal BPA
exposure showed a positive association with early childhood BMI, it
needs to be further evaluated which adiposity-associated genetic var-
iants, gene expression, and pathways are affected by IGF2Rmethylation
to explain causality and mechanisms. Also, cord blood was not available
in this study; thus, we could not compare dynamic methylation status at
Fig. 3. Chromosome locus and position of cg19196862 in IGF2R. Cg19196862 is included in the 31st exon of the IGF2R gene out of 48 exons.
Table 3
Association between methylation at cg19196862 (IGF2R gene) at age 2 and BMI at ages 2, 4, 6, and 8 (n = 59).*
Age Overall Boys Girls Sex difference (Reference: boys)
(Years) Estimate (95% CI) p-value Estimate (95% CI) p-value Estimate (95% CI) p-value Estimate p-value
BMI (kg/m2) 2 0.37 (0.06, 0.68) 0.024* 0.34 (-0.15, 0.83) 0.184 0.38 (0.00, 0.76) 0.0551 0.04 0.891
4 0.28 (0.00, 0.56) 0.055 0.14 (-0.30, 0.58) 0.530 0.37 (0.02, 0.72) 0.044* 0.23 0.414
6 0.29 (-0.11, 0.69) 0.167 −0.21 (-0.82, 0.41) 0.514 0.58 (0.10, 1.05) 0.022* 0.78 0.048*
8 0.64 (-0.09, 1.37) 0.096 −0.18 (-1.20, 0.86) 0.732 1.19 (0.32, 2.07) 0.011* 1.38 0.046*
2–8† 0.33 (-0.01, 0.67) 0.059 0.05 (-0.48, 0.58) 0.855 0.49 (0.08, 0.90) 0.019* 0.44 0.179
* Adjusted for mother’s age at pregnancy (years), mother’s and father’s BMI when a child first visited at age 2 (kg/m2), maternal smoking status (smoked during
pregnancy, did not smoke during pregnancy but smoked before pregnancy, and never smoked), mother’s educational level (middle school graduate, high school
graduate, college graduate, or graduate school attendance), preterm birth (< 37 weeks or ≥ 37 weeks), underweight at birth (< 2,500 g or ≥ 2,500 g), breast-
feeding duration (≥6 months or < 6 months), and child’s caloric intake (kcal/day) at ages 4, 6, and 8 (unavailable at age 2), and cell type fraction.
† Analyzed using a linear mixed model.
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birth and early childhood. The direct effect of prenatal BPA on child’s
BMI was not significant in this sub-study probably due to the small
sample size (n = 59); however, prenatal BPA levels showed a positive
association with children’s BMI in the EDC entire cohort (n = 657) in
our previous study (Lim et al. Manuscript submitted). Although the
present study did not unveil the epigenetic mechanism directly, we
suggested the potential role of DNA methylation in the obesogenic ef-
fects of prenatal BPA exposure. Since we targeted CpG sites derived
from previous obesity-related EWAS rather than conducting EWAS it-
self, the possibility of missing novel CpG sites related to BPA exposure
cannot be ruled out. EWAS are widely performed in detection of dif-
ferentially methylated CpG sites or regions associated with phenotype
or exposure as a data-driven approach. We attempted a ‘hypothesis-
driven’ analysis based on CpG sites drawn from previous ‘data-driven’
analyses to investigate epigenetic links between the environmental
exposure and clinical outcomes (Lim et al. 2017b).
However, this study was strengthened by its prospective study de-
sign including prenatal and postnatal exposure assessment, methylation
profiles at ages 2 and 6, and longitudinal outcome measurement from
ages 2, 4, 6, and 8 years, which enabled identification of the critical
window period of methylation change by prenatal BPA exposure. In
addition, sex-specific association between methylation at obesity-re-
lated CpG sites and early childhood BMI serves as one answer to explain
the suggesting sex-specific effects of prenatal BPA on childhood obesity.
To the best of our knowledge, this is the first human study to examine
sex-specific effects of methylation affected by prenatal BPA exposure.
The study of the mediation effect of methylation at IGF2R on the as-
sociation between prenatal BPA and childhood obesity also contributed
to the mechanism underlying the obesogenic effect of BPA. We also had
detailed information on obesity-associated covariates, including par-
ental BMI, birth history, breastfeeding, and early childhood caloric in-
take.
5. Conclusions
In utero exposure to BPA has been indicated as an obesogen in
children, and epigenetic regulation has been suggested as an underlying
mechanism, with limited evidence in humans. We found a single CpG
site that was more highly methylated at ages 2 but not at 6, by prenatal
BPA exposure among 594 targeted CpG sites from previous obesity-
related EWAS, which was further associated with BMI persistently from
ages 2 to 8 years in a sex-dependent manner.
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